What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Immunology, Cancer research, Cell biology, Molecular biology and Antigen.
Within one scientific family, Michael Bachmann focuses on topics pertaining to Cancer under Immunology, and may sometimes address concerns connected to Inflammation.
His studies in Cancer research integrate themes in fields like Cytotoxic T cell, Adoptive cell transfer, Interleukin 21 and Chimeric antigen receptor.
His Cell biology research is multidisciplinary, incorporating perspectives in Gene expression, Follicular dendritic cells, Bioluminescence imaging and Green fluorescent protein.
Michael Bachmann has researched Molecular biology in several fields, including Cell culture, Transfection, Biochemistry, Stem cell and Antibody.
His Antigen study incorporates themes from Systemic lupus erythematosus and Autoimmunity.
His most cited work include:
- Advances in In Vivo Bioluminescence Imaging of Gene Expression (733 citations)
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer (668 citations)
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells (542 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Molecular biology, Cancer research, Immunology, Antigen and Antibody.
The study incorporates disciplines such as Cytoplasm, Biochemistry, Gene, Messenger RNA and Ribonucleoprotein in addition to Molecular biology.
His Cancer research study integrates concerns from other disciplines, such as T cell, Chimeric antigen receptor, Cancer immunotherapy, Immunotherapy and In vivo.
His study looks at the relationship between In vivo and fields such as Bioluminescence imaging, as well as how they intersect with chemical problems.
His Immunology study combines topics in areas such as Mesenchymal stem cell and Cell biology.
He has included themes like Cytotoxic T cell, Virology and T-cell receptor in his Antigen study.
He most often published in these fields:
- Molecular biology (26.57%)
- Cancer research (27.07%)
- Immunology (25.31%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (27.07%)
- Chimeric antigen receptor (14.29%)
- Immunotherapy (13.53%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Chimeric antigen receptor, Immunotherapy, In vivo and Antigen.
His studies deal with areas such as Cancer cell, T cell, Immune system, Car t cells and Antibody as well as Cancer research.
His biological study spans a wide range of topics, including Epitope, Adoptive cell transfer, CD28 and CD19.
His Epitope research includes elements of Molecular biology and Hematologic Neoplasms.
The various areas that Michael Bachmann examines in his Immunotherapy study include Cytotoxicity and Cell biology.
His studies examine the connections between Antigen and genetics, as well as such issues in Recombinant DNA, with regards to Immunoglobulin light chain, Peptide sequence and DNA.
Between 2017 and 2021, his most popular works were:
- An intravascular magnetic wire for the high-throughput retrieval of circulating tumour cells in vivo (41 citations)
- Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology. (30 citations)
- From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo. (29 citations)
In his most recent research, the most cited papers focused on:
Michael Bachmann mainly investigates Cancer research, Chimeric antigen receptor, Immunotherapy, In vivo and Antigen.
His Cancer research research is multidisciplinary, incorporating elements of Cancer immunotherapy, Antibody, Immune system and Cytokine release syndrome.
His Chimeric antigen receptor research is multidisciplinary, relying on both CD28 and Adoptive cell transfer.
He interconnects Epitope, Cytotoxicity and Cell biology in the investigation of issues within Immunotherapy.
His biological study deals with issues like In vitro, which deal with fields such as Prostate Stem Cell Antigen and Recombinant DNA.
His Antigen research integrates issues from Myeloid, Leukemia, Haematopoiesis and B cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
